PD10-04 A POPULATION-BASED STUDY OF THE ASSOCIATION OF PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME (PSADT) WITH METASTASIS-FREE SURVIVAL (MFS) AND OVERALL SURVIVAL (OS) IN NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) PATIENTS (PTS)